Back to Stocks

OLN

OLIN Corp
7 filings tracked
materialsspecialty chemicalsMID ($2B-10B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Olin Corporation's first quarter 2026 results reveal a company navigating a temporary storm with strong structural tailwinds in its ammunition business.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

The financial results for the first quarter of 2026 highlight a concerning trend of margin erosion and deteriorating fundamentals across Olin's core operations.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every OLN filing.

Start Free Trial

Synthesis (Verdict & Resolution)

Olin's Q1 2026 filing depicts a company in a state of transition, where strong top-line growth in ammunition is clashing with deep operational struggles in its chemical segments. The reported net loss of $83 million is a composite of cyclical pricing headwinds and heavy one-time legal burdens, including a significant verdict in favor of Shintech. While the company has proactively amended its credit facilities to be less restrictive, the simultaneous downgrade by Fitch, Moody's, and S&P reflects a market skepticism regarding the speed of the recovery. The overall impact of the filing suggests a high-variance outcome for shareholders. The bull case relies on the successful execution of the Q2 recovery and the utilization of a massive share buyback program to support the stock. Conversely, the bear case warns that the company is essentially funding its capital returns and debt service through revolving credit while core margins continue to slide. The path forward depends on whether the military demand in Winchester can outpace the structural decay in the Chlor Alkali and Epoxy businesses.

Selected Quarter

Core Takeaway

Olin is experiencing a divergence between its ammunition growth and chemical margins, while battling significant one-time legal liabilities.

Investor Lens

The trade-off is between the secular growth of military ammunition and the cyclical, high-cost nature of the global chemical markets.

Watch Next

Q2 2026 operating results to verify management's guidance for a sequential improvement in chemical pricing and demand.

View Full SEC Report

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)-0.23Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bearishMay 8

Net loss of $83 million compared to a small profit in the prior year period.

earnings miss
80%
bearishMay 8

Gross margin fell from 9% to 5% due to pricing and raw material costs.

margin compression
70%
neutralMay 8

Amended senior credit facility to be less restrictive and eliminate term loan amortization.

debt restructure
50%
bullishMay 8

Maintains a massive $1.95 billion remaining share repurchase authorization.

buyback
60%
bearishMay 8

Net loss of $83 million compared to a small profit in the prior year period.

earnings miss
80%
bearishMay 8

Gross margin fell from 9% to 5% due to pricing and raw material costs.

margin compression
70%
neutralMay 8

Amended senior credit facility to be less restrictive and eliminate term loan amortization.

debt restructure
50%
bullishMay 8

Maintains a massive $1.95 billion remaining share repurchase authorization.

buyback
60%
bearishMay 8

Net loss of $83 million compared to a small profit in the prior year period.

earnings miss
80%
bearishMay 8

Gross margin fell from 9% to 5% due to pricing and raw material costs.

margin compression
70%
neutralMay 8

Amended senior credit facility to be less restrictive and eliminate term loan amortization.

debt restructure
50%
bullishMay 8

Maintains a massive $1.95 billion remaining share repurchase authorization.

buyback
60%
bearishMay 8

Net loss of $83 million compared to a small profit in the prior year period.

earnings miss
80%
bearishMay 8

Gross margin fell from 9% to 5% due to pricing and raw material costs.

margin compression
70%
neutralMay 8

Amended senior credit facility to be less restrictive and eliminate term loan amortization.

debt restructure
50%
bullishMay 8

Maintains a massive $1.95 billion remaining share repurchase authorization.

buyback
60%
bearishMay 8

Net loss of $83 million compared to a small profit in the prior year period.

earnings miss
80%
bearishMay 8

Gross margin fell from 9% to 5% due to pricing and raw material costs.

margin compression
70%
neutralMay 8

Amended senior credit facility to be less restrictive and eliminate term loan amortization.

debt restructure
50%
bullishMay 8

Maintains a massive $1.95 billion remaining share repurchase authorization.

buyback
60%
bearishMay 8

Net loss of $83 million compared to a small profit in the prior year period.

earnings miss
80%
bearishMay 8

Gross margin fell from 9% to 5% due to pricing and raw material costs.

margin compression
70%
neutralMay 8

Amended senior credit facility to be less restrictive and eliminate term loan amortization.

debt restructure
50%
bullishMay 8

Maintains a massive $1.95 billion remaining share repurchase authorization.

buyback
60%
bearishMay 8

Net loss of $83 million compared to a small profit in the prior year period.

earnings miss
80%
bearishMay 8

Gross margin fell from 9% to 5% due to pricing and raw material costs.

margin compression
70%
neutralMay 8

Amended senior credit facility to be less restrictive and eliminate term loan amortization.

debt restructure
50%
bullishMay 8

Maintains a massive $1.95 billion remaining share repurchase authorization.

buyback
60%

Filing History

10-QMay 8, 2026
Expand Sequence

Olin's Q1 2026 filing depicts a company in a state of transition, where strong top-line growth in ammunition is clashing with deep operational struggles in its chemical segments. The reported net loss of $83 million is a composite of cyclical pricing headwinds and heavy one-time legal burdens, including a significant verdict in favor of Shintech. While the company has proactively amended its credit facilities to be less restrictive, the simultaneous downgrade by Fitch, Moody's, and S&P reflects a market skepticism regarding the speed of the recovery. The overall impact of the filing suggests a high-variance outcome for shareholders. The bull case relies on the successful execution of the Q2 recovery and the utilization of a massive share buyback program to support the stock. Conversely, the bear case warns that the company is essentially funding its capital returns and debt service through revolving credit while core margins continue to slide. The path forward depends on whether the military demand in Winchester can outpace the structural decay in the Chlor Alkali and Epoxy businesses.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.